Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies.
Bingxian BianLi LiJunyao YangYi LiuGuohua XieYingxia ZhengLiang ZengJunxiang ZengLisong ShenPublished in: Cancer cell international (2019)
The available evidence supports the hypothesis that elevated serum/plasma YKL-40 is associated with poor survival in patients with solid tumors and that serum/plasma YKL-40 may serve as a novel prognostic biomarker.
Keyphrases